Protein S deficiency

 Protein S deficiency is a disorder associated with increased risk of venous thrombosis.[1] Protein S, a vitamin K-dependent physiological anticoagulant, acts as a nonenzymatic cofactor to activate protein C in the degradation of factor Va and factor VIIIa.[3]

Protein S deficiency
Protein PROS1 PDB 1z6c.png
Protein S structure
SpecialtyHematology 
SymptomsPurpura fulminans[1]
CausesVitamin K deficiency[1]
Diagnostic methodCoagulation test[1]
TreatmentHeparin, Warfarin[2]

Decreased (antigen) levels or impaired function of protein S leads to decreased degradation of factor Va and factor VIIIa and an increased propensity to venous thrombosis. Protein S circulates in human plasma in two forms: approximately 60 percent is bound to complement component C4b β-chain while the remaining 40 percent is free, only free protein S has activated protein C cofactor activity[medical citation needed]

Signs and symptomsEdit

Among the possible presentation of protein S deficiency are:[1][2][4]

  • Thrombosis of lower extremities
  • Superficial thrombophlebitis
  • Redness in affected area
  • Purpura fulminans

CauseEdit

Human Chr 3

In terms of the cause of protein S deficiency it can be in inherited via autosomal dominance. A mutation in the PROS1 gene triggers the condition. The cytogenetic location of the gene in question is chromosome 3, specifically 3q11.1[5][6] Protein S deficiency can also be acquired due to vitamin K deficiency, treatment with warfarinliver disease, and acute thrombosis (antiphospholipid antibodies may also be a cause as well)[1]

PathophysiologyEdit

In regards to the mechanism of protein S deficiency, Protein S is made in liver cells and the Endothelium.[7][8] Protein S is a cofactor of APC both work to degrade factor V and factor VIII. It has been suggested that Zn2+ might be necessary for Protein S binding to factor Xa.[2][9]

Mutations in this condition change amino acids, which in turn disrupts blood clotting. Functional protein S is lacking, which normally turns off clotting proteins, this increases risk of blood clots.[5]

DiagnosisEdit

PTT blood tests Vacutainer tube

The diagnosis for deficiency of protein S can be done via reviewing family history of condition and genetic testing, as well as the following:[1][10][11]

  • Protein S antigen test
  • Coagulation test (prothrombin time test)
  • Thrombotic disease investigation
  • Factor V Leiden test

Differential diagnosisEdit

Among the possibilities for differential diagnosis of protein S deficiency are- Antiphospholipid syndromedisseminated intravascular coagulation and antithrombin deficiency (though this list is not exhaustive)[2]

TypesEdit

There are three types of hereditary protein S deficiency:[2][5]

  • Type I – decreased protein S activity: decreased total protein S levels, as well as decreased free protein S levels
  • Type II – decreased in regards to the cofactor activity of the protein
  • Type III – decreased protein S activity: decreased free protein S levels (normal total protein S levels)

TreatmentEdit

Dabigatran

In terms of treatment for protein S deficiency the following are consistent with the management (and administration of) individuals with this condition (the prognosis for inherited homozygotes is usually in line with a higher incidence of thrombosis for the affected individual[1]):[2][9]

  • Unfractionated heparin (w/ warfarin)
  • LMWH/Low molecular weight heparin
  • Dabigatran
  • Direct Factor Xa Inhibitors
  • Graduated compressed stocking
  • High degree of prophylaxis

Note

This article uses material from the Wikipedia article
 Metasyntactic variable, which is released under the 
Creative Commons
Attribution-ShareAlike 3.0 Unported License
.